Carregant...
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
The BRAF inhibitor vemurafenib is currently used for treating patients with BRAF V600E mutant melanoma. However, the responses to vemurafenib are generally partial and of relatively short duration. Recent evidence suggests that activation of the epidermal growth factor receptor (EGFR)/erbB signaling...
Guardat en:
| Publicat a: | Melanoma Res |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394744/ https://ncbi.nlm.nih.gov/pubmed/24709886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000060 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|